select ad.sno,ad.journal,ad.title,ad.author_names,ad.abstract,ad.abstractlink,j.j_name,vi.* from articles_data ad left join journals j on j.journal=ad.journal left join vol_issues vi on vi.issue_id_en=ad.issue_id where ad.sno_en='13170' and ad.lang_id='8' and j.lang_id='8' and vi.lang_id='8' Gonadotropin Ovulation Induction (OI) and Intrauterine Insem | 13170
जर्नल ऑफ़ फर्टिलाइजेशन: इन विट्रो - आईवीएफ-वर्ल्डवाइड, रिप्रोडक्टिव मेडिसिन, जेनेटिक्स और स्टेम सेल बायोल

जर्नल ऑफ़ फर्टिलाइजेशन: इन विट्रो - आईवीएफ-वर्ल्डवाइड, रिप्रोडक्टिव मेडिसिन, जेनेटिक्स और स्टेम सेल बायोल
खुला एक्सेस

आईएसएसएन: 2375-4508

अमूर्त

Gonadotropin Ovulation Induction (OI) and Intrauterine Insemination IUI): An Outdated Therapy

Paul R Brezina

Traditionally, ovulation induction (OI) with intrauterine insemination (IUI) has been a strategy used to maximize pregnancy outcomes in patients attempting pregnancy. A common pattern of performing OI/IUI historically has been to begin OI using oral medications, such as Clomiphene Citrate or Letrozole, and then escalating medical management to include injectable Gonadotropins such as follicle stimulating hormone (FSH). However, current medical literature shows Gonadotropin IUI to be associated inferior to other available fertility therapies in terms of both medical risks and cost-effectiveness. Therefore, Gonadotropin IUI is now thought to be a suboptimal intervention for many patients. Based on current medical literature, the role of Gonadotropin IUI is likely to continually decline in the future. This trend will benefit patients by decreasing medical risks and increasing the cost-effectiveness of fertility treatments.

अस्वीकरण: इस सार का अनुवाद कृत्रिम बुद्धिमत्ता उपकरणों का उपयोग करके किया गया था और अभी तक इसकी समीक्षा या सत्यापन नहीं किया गया है।
Top add_chatinline();